SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge💹Economics📊Experiments🤖Agents🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
📖

Age-Sensitive Cortical Vulnerability in Parkinson's Disease

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-mechanisms-age-sensitive-cortical-v
Related Entities
mechanisms-age-sensitive-cortical-vulnerability-parkinsons
Metadata
slugmechanisms-age-sensitive-cortical-vulnerability-parkinsons
entity_typemechanism
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (343)
mentions🔬Senolytics targeting p16/p21+ senescent astrocytes and micro100%
mentions🧪Senescent Cell Mitochondrial DNA Release100%
mentions🧪SASP-Mediated Cholinergic Synapse Disruption100%
mentions🧪SASP-Mediated Complement Cascade Amplification100%
mentions🧪Senescence-Induced Lipid Peroxidation Spreading100%
mentions🧪SASP-Driven Aquaporin-4 Dysregulation100%
mentions🧪Senescence-Associated Myelin Lipid Remodeling100%
mentions🧪Senescence-Activated NAD+ Depletion Rescue100%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
mentions🧪Smartphone-Detected Motor Variability Correction66%
mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation65%
mentions🧪Enteric Nervous System Prion-Like Propagation Blockade64%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera60%
related🧫AAV-LRRK2 IND-Enabling Study Design60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD60%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%
related🧫Alpha-Synuclein Seed Amplification Assay Validation60%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%
related🧫Antiviral Therapy Trial for Parkinson's Disease60%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 60%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%
related🧫Combination Therapy Sequencing in Parkinson's Disease60%
related🧫CRISPR Gene Correction Approaches for CBS/PSP60%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa60%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%
related🧫Ferroptosis Validation in Parkinson's Disease60%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%
related🧫Cytochrome Therapeutics60%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%
related🧫Macroautophagy Dysfunction in PD - Experiment Design60%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P60%
related🧫Validation: Membrane-Nucleation in iPSC Neurons60%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag60%
related🧫MLCS Quantification in Parkinson's Disease60%
related🧫Experiment: Multi-Ethnic PD GWAS60%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin60%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'60%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%
related🧫Parkinson's Disease Subtype Classification — Precision 60%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%
related🧫Prodromal Parkinson's Disease Biomarker Development — E60%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson60%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise60%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di60%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%
see_also📖Alpha-Synuclein Seed Kinetic Staging in Parkinson's Dis60%
see_also📖AT(N) Biomarker Classification for Alzheimer's Disease60%
see_also📖A/T/N+ Comprehensive Biomarker Panel for Alzheimer's Di60%
see_also📖Combination Biomarker Panels for Alzheimer's Disease60%
see_also📖Cholinergic Basal Forebrain Neurons in Alzheimer's Dise60%
see_also📖Cortical Layer 5 Pyramidal Neurons in Alzheimer's Disea60%
see_also📖Dentate Gyrus Granule Cells in Alzheimer's Disease60%
see_also📖Disease-Associated Microglia in Alzheimer's Disease60%
see_also📖dopaminergic-vta-pd60%
see_also📖Dorsal Raphe Serotonergic Neurons in Parkinson's Diseas60%
see_also📖Layer 2 Entorhinal Cortex Neurons in Early Alzheimer's 60%
see_also📖Entorhinal Cortex Layer II Neurons in Alzheimer's Disea60%
see_also📖Globus Pallidus Internus in Parkinsons Disease60%
see_also📖Layer 2 Entorhinal Cortex Neurons in Alzheimer Disease60%
see_also📖Locus Coeruleus Noradrenergic Neurons in Alzheimer's Di60%
see_also📖Locus Coeruleus Noradrenergic Neurons in Alzheimer's Di60%
see_also📖Locus Coeruleus Norepinephrine in AD60%
see_also📖Melanocytes in Parkinson Disease60%
see_also📖Nigrostriatal Dopamine Terminals in Parkinson's Disease60%
see_also📖Dopaminergic Substantia Nigra Neurons in Parkinson's Di60%
see_also📖Temporal Cortex Neurons in Alzheimer's Disease60%
see_also📖Vulnerable Dopaminergic Neurons in Parkinson's Disease60%
see_also📖AB-1005 (REGENERATE-PD) GDNF Gene Therapy Trial60%
see_also📖ABBV-951 (foslevodopa/foscarbidopa) for Parkinson's Dis60%
see_also📖AMDX-2011P Phase 2 Trial for Alzheimer's Disease60%
see_also📖AMDX-2011P Retinal Amyloid Tracer in Alzheimer's Diseas60%
see_also📖Apocynin for Parkinson's Disease60%
see_also📖Bacillus Subtilis for Parkinson Disease (NCT06487975)60%
see_also📖Benfotiamine Phase 2 Alzheimer's Disease Trial (NCT062260%
see_also📖biib122-luma-lrrk2-inhibitor-pd60%
see_also📖Bilingualism Cognitive Reserve AD Trial60%
see_also📖CT1-DAP001 iPS Cell-derived Dopaminergic Progenitors for Par60%
see_also📖CVN424 Phase 3 ARISE Trial for Parkinson's Disease60%
see_also📖Intranasal Insulin and Glutathione for PD (NOSE-PD)60%
see_also📖Lactococcus lactis CKDB001 for Alzheimer's Disease (NCT60%
see_also📖LY-3372689 MAGNOLIA Trial - Phase 2 in Alzheimer's Dise60%
see_also📖Methylphenidate + iTBS for Apathy in AD (PRIME Trial)60%
see_also📖MK-1167 Phase 2 Alzheimer's Disease Trial60%
see_also📖NCT05565443: MR-Guided Focused Ultrasound + GCase for Parkin60%
see_also📖Gabapentin Enacarbil Phase 4 Trial - Nighttime Agitation60%
see_also📖NCT04840979 - Genetic Variants Affecting Microglial Activati60%
see_also📖nct05266417-nose-pd60%
see_also📖nct06365190-rtms-pd60%
see_also📖NCT06487975: Bacillus Subtilis Gut Microbiome Intervention f60%
see_also📖Autologous Stem Cell-Derived Dopaminergic Neurons for Parkin60%
see_also📖Dyadic Mindfulness for PD Carers (NCT06821230)60%
see_also📖Amino Acid Supplement in Parkinson's Disease (NCT06954660%
see_also📖NCT07138677: MCI Network Guided TMS for Early Alzheimer'60%
see_also📖RO7812653 for Early Symptomatic Alzheimer's Disease60%
see_also📖Vibrotactile Stimulation Walking Speed PD Trial60%
see_also📖Noradrenergic Arousal System Phase 3 PD Trial (NCT07316296)60%
see_also📖tDCS + Nordic Walking for Parkinson's Disease Motor Sym60%
see_also📖NouvNeu001 Cell Therapy for Parkinson's Disease60%
see_also📖PDE4 Inhibitor PD Trial60%
see_also📖Retigabine PD Trial60%
see_also📖TTYP01 Phase 2 Alzheimer's Disease Trial60%
see_also📖Valacyclovir for HSV-1-Positive Parkinson's Disease60%
see_also📖NCT05881460: Vibrotactile Coordinated Reset for Parkinson&#x60%
see_also📖XTR006 Tau PET for Alzheimer's Disease (NCT07115238)60%
see_also📖Accelerating Medicines Partnership Alzheimer's Disease 60%
see_also📖AMP-PD: Accelerating Medicines Partnership: Parkinson's60%
see_also📖Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%
see_also📖Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%
see_also📖Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%
see_also📖Experiment: Autoimmune Hypothesis Testing in AD60%
see_also📖Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 60%
see_also📖Combination Therapy Sequencing in Parkinson's Disease60%
see_also📖Selective Vulnerability of Dopaminergic Neurons — Mechanism 60%
see_also📖GLP-1 Agonist Responder Prediction Study — Precision Medicin60%
see_also📖Non-Motor Symptom Progression in Parkinson's Disease — 60%
see_also📖SCFA-Mediated Neuroinflammation in Alzheimer's Disease60%
see_also📖Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
see_also📖Accelerating Medicines Partnership for Alzheimer's Dise60%
see_also📖Accelerating Medicines Partnership for Parkinson's Dise60%
see_also📖Packard Center for ALS Research60%
see_also📖Cholinergic Hypothesis in Alzheimer's Disease60%
see_also📖Dopaminergic Neurodegeneration60%
see_also📖Fibrinogen and αVβ3 Integrin in Alpha-Synuclein Pathology60%
see_also📖Glia-Neuron Crosstalk in Alzheimer's Disease60%
see_also📖Glymphatic System in Alzheimer's Disease60%
see_also📖Infectious Etiology Hypotheses in Alzheimer's Disease60%
see_also📖Infectious Triggers in Alzheimer's Disease60%
see_also📖Innate Immune Signaling Pathways in Alzheimer's Disease60%
see_also📖Integrated Stress Response in Alzheimer's Disease60%
see_also📖Microglial State Trajectory from Mobilization to Dysregulati60%
see_also📖mitochondrial-dysfunction-ad60%
see_also📖MLCS Quantification Methods in Parkinson's Disease Rese60%
see_also📖Neuronal Death Pathways in Alzheimer's Disease60%
see_also📖Pallido-Thalamocortical Motor Pathway in Parkinson's Di60%
see_also📖PDLIM7 Epigenetic Activation in Parkinson's Disease60%
see_also📖PKM2 Metabolic Dysregulation in Alzheimer's Disease60%
see_also📖psilocybin-neuropsychiatric-ad60%
see_also📖RNA Metabolism Dysregulation in Alzheimer's Disease60%
see_also📖SAA and Imaging for Prodromal Parkinson's Disease Trial60%
see_also📖Sleep Disruption in Alzheimer's Disease60%
see_also📖Vascular Contributions to Alzheimer's Disease60%
see_also📖Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD)60%
see_also📖AI-Powered Movement Analysis for Parkinson's Disease60%
see_also📖Digital Biomarker Platforms for Parkinson's Disease60%
see_also📖Digital Therapeutics for Parkinson's Disease60%
see_also📖Wearable Sensors for Parkinson's Disease60%
see_also📖Adenosine A2A Receptor Antagonists60%
see_also📖CAR-A (Chimeric Antigen Receptor) Astrocyte Therapy for Alzh60%
see_also📖CUE1 Non-Invasive Vibrotactile Device for Parkinson's D60%
see_also📖Ferulic Acid Carbamate Derivatives for Alzheimer's Dise60%
see_also📖Neurorestore Therapies for Parkinson's Disease60%
see_also📖Synaptic Plasticity Therapeutics for Parkinson's Diseas60%
see_also📖Amyloid-Related Imaging Abnormalities (ARIA)60%
see_also📖Parkinson Basal Ganglia Circuit60%
see_also📖Autophagy Enhancement Drug Screening for Neurodegeneration60%
see_also📖diseases-amyotrophic-lateral-sclerosis60%
see_also📖Dementia Australia60%
related🧪Smartphone-Detected Motor Variability Correction59%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation58%
related🧪Enteric Nervous System Prion-Like Propagation Blockade57%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera54%
related🧫AAV-LRRK2 IND-Enabling Study Design54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD54%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%
related🧫Alpha-Synuclein Seed Amplification Assay Validation54%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%
related🧫Antiviral Therapy Trial for Parkinson's Disease54%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%
related🧫Combination Therapy Sequencing in Parkinson's Disease54%
related🧫CRISPR Gene Correction Approaches for CBS/PSP54%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa54%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#54%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise54%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%
related🧫Ferroptosis Validation in Parkinson's Disease54%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%
related🧫Cytochrome Therapeutics54%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%
related🧫Macroautophagy Dysfunction in PD - Experiment Design54%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P54%
related🧫Validation: Membrane-Nucleation in iPSC Neurons54%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag54%
related🧫MLCS Quantification in Parkinson's Disease54%
related🧫Experiment: Multi-Ethnic PD GWAS54%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'54%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise54%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%
related🧫Parkinson's Disease Subtype Classification — Precision 54%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%
related🧫Prodromal Parkinson's Disease Biomarker Development — E54%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise54%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di54%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%
mentions🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#50%
mentions🧪Temporal Decoupling via Circadian Clock Reset50%
mentions🧪Circadian Clock-Autophagy Synchronization50%
mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬What are the mechanisms underlying mechanistic role of apoe 50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬What are the mechanisms by which tau pathology spreads throu50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
related🔬Why do entorhinal cortex layer II stellate neurons die first50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
mentions🔬Analyze circuit-level changes in neurodegeneration using All40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬What are the mechanisms underlying selective vulnerability o40%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp40%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
mentions🔬What are the mechanisms underlying astrocyte reactivity subt40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
mentions🔬What are the mechanisms underlying microglia-astrocyte cross40%
mentions🔬What are the mechanisms underlying apoe4 structural biology 40%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
mentions🔬What are the mechanisms underlying digital biomarkers and ai40%
mentions🔬What are the mechanisms underlying senolytic therapy for age40%
mentions🔬What are the mechanisms underlying neuroinflammation resolut40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying mitochondrial transfer be40%
mentions🔬What are the mechanisms underlying protein aggregation cross40%
mentions🔬What are the mechanisms underlying mechanistic role of apoe 40%
mentions🔬What are the mechanisms underlying sleep disruption as cause40%
mentions🔬What are the mechanisms underlying rna binding protein dysre40%
mentions🔬What are the mechanisms underlying synaptic pruning by micro40%
mentions🔬What are the mechanisms underlying mitochondrial transfer be40%
mentions🔬What are the mechanisms underlying epigenetic clocks and bio40%
mentions🔬What are the mechanisms underlying perivascular spaces and g40%
mentions🔬What are the mechanisms by which tau pathology spreads throu40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬Why do entorhinal cortex layer II stellate neurons die first40%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy40%
related🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro40%
related🧪Oligodendrocyte White Matter Vulnerability35%
related🧪Age-Dependent Complement C4b Upregulation Drives Synaptic Vu35%
related🧪Complement C1QA Spatial Gradient in Cortical Layers35%
related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation35%

💬 Discussion

SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub